Xuefang Liu

发表

Effective-component compatibility of Bufei Yishen formula protects COPD rats against PM2.5-induced oxidative stress via miR-155/FOXO3a pathway.

P. Zhao, Jiansheng Li, Ya Li, 2021, Ecotoxicology and environmental safety.

Systematic characterization of the effective constituents and molecular mechanisms of Ardisiae Japonicae Herba using UPLC-Orbitrap Fusion MS and network pharmacology

Jiansheng Li, Yange Tian, Xuefang Liu, 2022, PloS one.

Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula.

P. Zhao, Jiansheng Li, Yange Tian, 2018, Journal of ethnopharmacology.

Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology

Yange Tian, Xuefang Liu, S. Feng, 2022, Scientific Reports.

Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori

Siguo Liu, Juan Luo, Jianquan Chen, 2015, International journal of molecular medicine.

Three Tiaobu Feishen formulae reduces cigarette smoke-induced inflammation in human airway epithelial cells.

Yulong Chen, P. Zhao, Jiansheng Li, 2020, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

Effective-Component Compatibility of Bufei Yishen Formula Ⅲ Ameliorated COPD By Improving Airway Epithelial Cell Senescence Via Promoting Mitophagy By Nrf2/PINK1 Pathway

P. Zhao, B. Oliver, Yange Tian, 2022 .

miRNA‐206 regulates human pulmonary microvascular endothelial cell apoptosis via targeting in chronic obstructive pulmonary disease

P. Zhao, Jiansheng Li, Yange Tian, 2018, Journal of cellular biochemistry.

Three Tiaobu Feishen therapies protect human alveolar epithelial cells against cigarette smoking and tumor necrosis factor--induced inflammation by nuclear factor-kappa B pathway.

Yulong Chen, P. Zhao, Jiansheng Li, 2019, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease.

P. Zhao, Jiansheng Li, Yange Tian, 2020, Journal of integrative medicine.

Network pharmacology combined with pharmacodynamics revealed the anti-inflammatory mechanism of Tanreqing capsule against acute-exacerbation chronic obstructive pulmonary disease

Yange Tian, Xuefang Liu, S. Feng, 2022, Scientific Reports.

Mechanisms of the lipopolysaccharide-induced inflammatory response in alveolar epithelial cell/macrophage co-culture

Yulong Chen, P. Zhao, Jiansheng Li, 2020, Experimental and therapeutic medicine.

Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.

P. Zhao, Jiansheng Li, Yange Tian, 2020, Journal of ethnopharmacology.

A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38.

P. Zhao, Jiansheng Li, B. Oliver, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway

P. Zhao, B. Oliver, Yange Tian, 2022, BMC Pulmonary Medicine.

Simultaneous quantitation of 31 bioactive components in different parts of Ardisiae Japonicae Herba from different regions by UPLC-Orbitrap Fusion MS

Yange Tian, Xuefang Liu, S. Feng, 2021, Journal of Liquid Chromatography & Related Technologies.

Pharmacodynamics of Five Anthraquinones (Aloe-emodin, Emodin, Rhein, Chysophanol, and Physcion) and Reciprocal Pharmacokinetic Interaction in Rats with Cerebral Ischemia

N. Zhang, Xuefang Liu, Rong-Rong Li, 2019, Molecules.

LPS‑induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF‑κB, STAT3 or AP‑1 activation.

Yulong Chen, P. Zhao, Jiansheng Li, 2018, Molecular medicine reports.

The pharmacokinetic study of Tanreqing and the interaction with cefixime in rat model of pneumonia by validated UPLC-MS/MS.

Yange Tian, Xuefang Liu, S. Feng, 2021, Journal of pharmaceutical and biomedical analysis.

Effective-components combination improves airway remodeling in COPD rats by suppressing M2 macrophage polarization via the inhibition of mTORC2 activity.

P. Zhao, Jiansheng Li, Yange Tian, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

A high-resolution MS/MS based strategy to improve xenobiotic metabolites analysis by metabolic pathway extension searching combined with parallel reaction monitoring: Flavonoid metabolism in wound site as a case.

P. Zhao, Jiansheng Li, Xuefang Liu, 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor

P. Zhao, Jiansheng Li, Yange Tian, 2020, Frontiers in Pharmacology.

Exposure to Air Pollution Exacerbates Inflammation in Rats with Preexisting COPD

P. Zhao, Jiansheng Li, B. Oliver, 2020, Mediators of inflammation.

Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS

P. Zhao, Jiansheng Li, Jinyan Wu, 2022, International Journal of Analytical Chemistry.

Simultaneous Determination of Multiple Components in Jinshui Huanxian Granules by UPLC–Orbitrap Fusion MS

Xuefang Liu, Hong-Xin Cui, S. Feng, 2022, Chromatographia.

Lipopolysaccharide induces epithelial–mesenchymal transition of alveolar epithelial cells cocultured with macrophages possibly via the JAK2/STAT3 signaling pathway

P. Zhao, Y. Chen, Xuefang Liu, 2020, Human & experimental toxicology.